| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94.6M | — | — |
| Cost of Revenue | $1.2M | — | — |
| R&D Expense | $11.3M | — | -16.6% |
| SG&A Expense | $50.4M | — | +72.1% |
| Operating Income | $31.3M | — | +168.4% |
| Interest Expense | $1.3M | — | -5.1% |
| Pre-tax Income | $34.9M | — | +179.8% |
| Income Tax | $3.5M | — | — |
| Net Income | $31.4M | — | +171.7% |
| EPS (Basic) | $0.60 | — | +163.2% |
| EPS (Diluted) | $0.59 | — | +162.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $133.0M | +89.7% | +63.6% |
| Short-term Investments | $122.6M | -47.9% | -41.2% |
| Accounts Receivable | $47.1M | +67.1% | — |
| Inventory | $17.3M | +15.2% | — |
| Current Assets | $326.4M | -8.3% | +5.7% |
| Total Assets | $608.4M | +7.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $26.0M | — | +179.3% |
| Capital Expenditures | $40K | — | +700.0% |
| Investing Cash Flow | $38.0M | — | +65.6% |
| Financing Cash Flow | -$1.0M | — | -132.4% |
| Free Cash Flow | $25.9M | — | +179.2% |
| +91.3% |
| Current Liabilities | $58.0M | -5.4% | +269.0% |
| Long-term Debt | $49.9M | +0.1% | +0.1% |
| Total Liabilities | $112.6M | -1.0% | +31.2% |
| Stockholders' Equity | $495.8M | +10.1% | +113.5% |